Results 161 to 170 of about 11,135 (204)

Modulating efferocytosis in the intestinal epithelial cells during colorectal cancer. [PDF]

open access: yesFront Oncol
Boeckaerts L   +8 more
europepmc   +1 more source

Exclusion of Notch from the contact site during efferocytosis restricts anticancer immunity. [PDF]

open access: yesNat Immunol
Li Z   +10 more
europepmc   +1 more source

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer. [PDF]

open access: yesSignal Transduct Target Ther
Guo X   +19 more
europepmc   +1 more source

Death as rebirth: how efferocytosis drives tissue repair and disease treatment. [PDF]

open access: yesFront Immunol
Duan X   +7 more
europepmc   +1 more source

Efferocytosis and Respiratory Disease

open access: yesInternational Journal of Molecular Sciences, 2023
Cells are the smallest units that make up living organisms, which constantly undergo the processes of proliferation, differentiation, senescence and death. Dead cells need to be removed in time to maintain the homeostasis of the organism and keep it healthy. This process is called efferocytosis.
Guoqiang Wang, Xu Zuo, Fang Wang
exaly   +3 more sources

Macrophage efferocytosis in atherosclerosis

Scandinavian Journal of Immunology, 2023
AbstractThis paper presents the role of macrophage efferocytosis, the process of elimination of apoptotic bodies—elements formed during vascular atherosclerosis. The mechanisms of macrophage efferocytosis are presented, introducing the specific signals of this process, that is, ‘find me’, ‘eat me’ and ‘don't eat me’.
Wiesław Deptuła   +2 more
exaly   +3 more sources

The Role of Efferocytosis in Atherosclerosis [PDF]

open access: yesCirculation, 2017
The necrotic core has long been a hallmark of the vulnerable atherosclerotic plaque. Although apoptotic cells are cleared quickly in almost all other tissue beds, their removal appears to be significantly impaired in the diseased blood vessel. Emerging evidence indicates that this phenomenon is caused by a defect in efferocytosis, the process by which ...
Nicholas Leeper   +2 more
exaly   +3 more sources

What’s the deal with efferocytosis and asthma?

Trends in Immunology, 2021
Mucosal sites, such as the lung, serve as crucial, yet vulnerable barriers to environmental insults such as pathogens, allergens, and toxins. Often, these exposures induce massive infiltration and death of short-lived immune cells in the lung, and efficient clearance of these cells is important for preventing hyperinflammation and resolving ...
Donald Cook, Jennifer Martinez
exaly   +3 more sources

Home - About - Disclaimer - Privacy